BioCentury
ARTICLE | Company News

Canada approves Syn X brain injury tests

January 27, 2003 8:00 AM UTC

Canada granted marketing clearance for two traumatic brain injury tests from Syn X Pharma (TSE:SYY). The Nexus Dx neuron specific enolase (NSE) and Nexus Dx S-100 ELISA tests measure the biochemical m...